Hemophilia

Study Looks At Genomic Variability Of Hepatitis C In Patients Coinfected With HCV/HIV

Published in Hepatitis Weekly, August 13th, 2001

The University of Cincinnati (UC) College of Medicine has received a $2.5 million grant from the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health to study the genomic variability of hepatitis C virus (HCV) in infected hemophiliac patients also infected with HIV.

Hemophilia is a bleeding disorder in which certain factors in the blood needed to form a clot are missing or reduced, resulting in difficulty controlling hemorrhage.

"Hemophiliacs infected with both hepatitis C and HIV have more rapidly progressive liver failure than patients with hepatitis C alone," explained Kenneth Sherman, MD, PhD, associate...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-08-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry